
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16283702
[patent_doc_number] => 20200277304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
[patent_app_type] => utility
[patent_app_number] => 16/818512
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818512 | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | Mar 12, 2020 | Issued |
Array
(
[id] => 16190751
[patent_doc_number] => 20200231600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => SUBSTITUTED AMINOTHIAZOLOPYRIMIDINEDIONES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/816940
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/816940 | Substituted aminothiazolopyrimidinediones for the treatment of virus infection | Mar 11, 2020 | Issued |
Array
(
[id] => 17609783
[patent_doc_number] => 20220152062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/436225
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436225 | USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES | Mar 3, 2020 | Pending |
Array
(
[id] => 17704521
[patent_doc_number] => 20220204527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => FUSED TRICYCLIC COMPOUNDS USEFUL AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/436137
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436137 | Fused tricyclic compounds useful as anticancer agents | Mar 2, 2020 | Issued |
Array
(
[id] => 17704521
[patent_doc_number] => 20220204527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => FUSED TRICYCLIC COMPOUNDS USEFUL AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/436137
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436137 | Fused tricyclic compounds useful as anticancer agents | Mar 2, 2020 | Issued |
Array
(
[id] => 17307298
[patent_doc_number] => 11208390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
[patent_app_type] => utility
[patent_app_number] => 16/807037
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16768
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807037
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807037 | Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions | Mar 1, 2020 | Issued |
Array
(
[id] => 16111445
[patent_doc_number] => 20200207745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => Pyrimidine Derivative, Method For Preparing Same And Use Thereof In Medicine
[patent_app_type] => utility
[patent_app_number] => 16/800057
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800057 | Pyrimidine derivative, method for preparing same and use thereof in medicine | Feb 24, 2020 | Issued |
Array
(
[id] => 17576840
[patent_doc_number] => 20220133695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => SINGLE-DOSE PACKAGED CLOTRIMAZOLE LIQUID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/310260
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310260
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310260 | Single-dose packaged clotrimazole liquid composition | Feb 17, 2020 | Issued |
Array
(
[id] => 15990603
[patent_doc_number] => 20200171172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 16/787480
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787480 | Compounds, systems, and methods for monitoring and treating a surface of a subject | Feb 10, 2020 | Issued |
Array
(
[id] => 15993303
[patent_doc_number] => 20200172522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METHODS FOR PREPARING OLTIPRAZ
[patent_app_type] => utility
[patent_app_number] => 16/784915
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784915 | METHODS FOR PREPARING OLTIPRAZ | Feb 6, 2020 | Abandoned |
Array
(
[id] => 16009097
[patent_doc_number] => 20200179391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/780628
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780628 | Compounds and compositions for the treatment of parasitic diseases | Feb 2, 2020 | Issued |
Array
(
[id] => 15993271
[patent_doc_number] => 20200172506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
[patent_app_type] => utility
[patent_app_number] => 16/780704
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780704 | Inhibitors of lysine specific demethylase-1 | Feb 2, 2020 | Issued |
Array
(
[id] => 17490399
[patent_doc_number] => 11279688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Inhibitors of RET
[patent_app_type] => utility
[patent_app_number] => 16/775646
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17918
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775646
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775646 | Inhibitors of RET | Jan 28, 2020 | Issued |
Array
(
[id] => 17104290
[patent_doc_number] => 11124485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
[patent_app_type] => utility
[patent_app_number] => 16/773411
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30035
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 490
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773411 | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage | Jan 26, 2020 | Issued |
Array
(
[id] => 15930961
[patent_doc_number] => 20200157114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/748191
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748191 | Optically active azabicyclo ring derivative | Jan 20, 2020 | Issued |
Array
(
[id] => 17407132
[patent_doc_number] => 11248001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => PCSK9 inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/744929
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69319
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744929 | PCSK9 inhibitors and methods of use thereof | Jan 15, 2020 | Issued |
Array
(
[id] => 18237576
[patent_doc_number] => 20230069886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE
[patent_app_type] => utility
[patent_app_number] => 17/791657
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791657 | AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE | Jan 9, 2020 | Pending |
Array
(
[id] => 16962839
[patent_doc_number] => 20210214338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => 1,3-DIPOLAR CYCLOADDITIONS, AND STAUDINGER LIGATIONS FOR CONJUGATING BIOMOLECULES USING CLICK CHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 16/740153
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/740153 | 1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry | Jan 9, 2020 | Issued |
Array
(
[id] => 16948028
[patent_doc_number] => 20210206719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/740083
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 389
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/740083 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | Jan 9, 2020 | Issued |
Array
(
[id] => 16735810
[patent_doc_number] => 10961447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material
[patent_app_type] => utility
[patent_app_number] => 16/737913
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3889
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737913 | Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material | Jan 8, 2020 | Issued |